|
KBTBD6 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.42069999995187E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.1686999999937E-05 |
| Normal-vs-Stage2 |
1.169960E-01 |
| Normal-vs-Stage3 |
5.3730000004748E-07 |
| Normal-vs-Stage4 |
4.67670000503517E-08 |
| Stage1-vs-Stage2 |
3.250000E-02 |
| Stage1-vs-Stage3 |
9.784100E-02 |
| Stage1-vs-Stage4 |
1.500340E-02 |
| Stage2-vs-Stage3 |
3.703900E-03 |
| Stage2-vs-Stage4 |
4.636100E-04 |
| Stage3-vs-Stage4 |
2.404400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.23600000001556E-06 |
| Normal-vs-AfricanAmerican |
1.481490E-03 |
| Normal-vs-Asian |
2.25139999999735E-05 |
| Caucasian-vs-AfricanAmerican |
9.545400E-01 |
| Caucasian-vs-Asian |
9.115800E-01 |
| AfricanAmerican-vs-Asian |
8.948400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.65780000002969E-06 |
| Normal-vs-Female |
1.50004999999176E-05 |
| Male-vs-Female |
9.735200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.52584999999483E-05 |
| Normal-vs-Age(41-60Yrs) |
3.54759999998677E-06 |
| Normal-vs-Age(61-80Yrs) |
2.14039999999471E-05 |
| Normal-vs-Age(81-100Yrs) |
1.069560E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.126400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.361000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.103600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.077200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.451400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.786800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.978830E-04 |
| Classical-VS-Follicular |
1.386630E-04 |
| Classical-VS-Other |
8.157200E-01 |
| Classical-VS-Normal |
4.11060000005126E-06 |
| Tall-VS-Follicular |
6.99470004139613E-09 |
| Tall-VS-Other |
2.778400E-01 |
| Tall-VS-Normal |
1.35379996102358E-09 |
| Follicular-VS-Other |
3.445200E-01 |
| Follicular-VS-Normal |
3.359900E-02 |
| Other-VS-Normal |
1.008790E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.17840000000092E-05 |
| Normal-vs-N1 |
1.57799995292862E-09 |
| N0-vs-N1 |
2.5896999999997E-06 |
|
|
